Intra-Operative GPS for
Critical Limb Ischemia —
Objective Tissue Perfusion Data in Real Time
For the first time, vascular surgeons have an objective, continuous measurement of tissue oxygen levels throughout CLI intervention and for 28 days post-operatively — enabling data-driven decisions that were previously impossible.
Clinicians Deserve More Than Clinical Intuition
Today, approximately 6.5 million patients globally suffer from Critical Limb Ischemia — a severe blockage of the arteries that reduces blood flow and oxygen to the limbs. Despite more than 1.1 million procedures performed annually in the US and EU, treatment decisions remain largely based on clinical experience alone. There is currently no tool that provides objective, real-time data about tissue perfusion during or after intervention.
Lumee™ Oxygen changes that.
Real-Time Tissue Oxygen Data.
Delivered Continuously.
The Lumee™ Oxygen system includes three components:
Injected subcutaneously at the site of interest via standard hypodermic needle. Remains in place and functional for up to 9+ months with no surgical removal required.
Worn on the skin over the sensor site. Reusable optoelectronic reader that continuously interrogates the sensor and transmits data via Bluetooth.
iOS/Android compatible application displays real-time Lumee Oxygen Index (LOI). Enables remote patient monitoring.
- ~6.5M patients in US, Europe, and Japan
- ~$4.9B market in 2022 growing at 8% CAGR
- ~1.1M CLI procedures annually (US + EU)
- 716,000 EU procedures estimated in 2025
- 425,000 US procedures estimated in 2025
- Germany: ~110,000 procedures/year
- France: ~60,000 procedures/year d
- Italy: ~50,000 procedures/year
- Tier 2: Austria, Benelux, Switzerland, Greece
- Distribution covering ~35% of EU procedures already secured
A Clear Revenue Model at Scale
| Revenue Stream | Price | Unit |
|---|---|---|
| Procedure Revenue | €600 – €800 per procedure | 4 sensors + 4 pens per CLI case |
| Starter Kit | €10,000 per kit | iPad + preloaded software + sensors + adhesives |
| Kits per Center | 3 kits per center/year | Covers 1,000–1,500 high-volume or 200–1,000 ambulatory procedures |
EU Launch Partners
AngioPro (Germany) — Covers ~30% of EU population, access to key European markets
Dismeval, S.L. (Spain) — Covers Spanish CLI procedure volume
Austria Medical Center — Dr. Marianne Brodmann (~1,500 procedures/year)
Paris Vascular Center — Dr. Yann Goeffic (~8% of France's CLI procedures)
Belgium Vascular Center — Dr. Koen R. Deloose
Further distribution partnerships planned to expand EU market coverage beyond the current ~35%.
See the full EU revenue roadmap, financial projections, and funding runway.
View Financial Overview→Request clinical data, ask about EU availability, or schedule a product demonstration.
Request Clinical Info →